Literature DB >> 24414419

Stratifying fascin and cortactin function in invadopodium formation using inhibitory nanobodies and targeted subcellular delocalization.

Isabel Van Audenhove1, Ciska Boucherie, Leen Pieters, Olivier Zwaenepoel, Berlinda Vanloo, Evelien Martens, Charlotte Verbrugge, Gholamreza Hassanzadeh-Ghassabeh, Joël Vandekerckhove, Maria Cornelissen, Ariane De Ganck, Jan Gettemans.   

Abstract

Invadopodia are actin-rich protrusions arising through the orchestrated regulation of precursor assembly, stabilization, and maturation, endowing cancer cells with invasive properties. Using nanobodies (antigen-binding domains of Camelid heavy-chain antibodies) as perturbators of intracellular functions and/or protein domains at the level of the endogenous protein, we examined the specific contribution of fascin and cortactin during invadopodium formation in MDA-MB-231 breast and PC-3 prostate cancer cells. A nanobody (K(d)~35 nM, 1:1 stoichiometry) that disrupts fascin F-actin bundling emphasizes the importance of stable actin bundles in invadopodium array organization and turnover, matrix degradation, and cancer cell invasion. Cortactin-SH3 dependent WIP recruitment toward the plasma membrane was specifically inhibited by a cortactin nanobody (K(d)~75 nM, 1:1 stoichiometry). This functional domain is shown to be important for formation of properly organized invadopodia, MMP-9 secretion, matrix degradation, and cancer cell invasion. Notably, using a subcellular delocalization strategy to trigger protein loss of function, we uncovered a fascin-bundling-independent role in MMP-9 secretion. Hence, we demonstrate that nanobodies enable high resolution protein function mapping in cells.

Entities:  

Keywords:  cytoskeletal protein modulation; heavy-chain only antibodies; invasive protrusions; oncotargets

Mesh:

Substances:

Year:  2014        PMID: 24414419     DOI: 10.1096/fj.13-242537

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  25 in total

1.  Chaperone nanobodies protect gelsolin against MT1-MMP degradation and alleviate amyloid burden in the gelsolin amyloidosis mouse model.

Authors:  Wouter Van Overbeke; Adriaan Verhelle; Inge Everaert; Olivier Zwaenepoel; Joël Vandekerckhove; Claude Cuvelier; Wim Derave; Jan Gettemans
Journal:  Mol Ther       Date:  2014-07-15       Impact factor: 11.454

2.  Intracellular displacement of p53 using transactivation domain (p53 TAD) specific nanobodies.

Authors:  Anneleen Steels; Adriaan Verhelle; Olivier Zwaenepoel; Jan Gettemans
Journal:  MAbs       Date:  2018-09-11       Impact factor: 5.857

Review 3.  Single domain antibodies for the knockdown of cytosolic and nuclear proteins.

Authors:  Thomas Böldicke
Journal:  Protein Sci       Date:  2017-03-24       Impact factor: 6.725

4.  Epstein-Barr virus and its association with Fascin expression in colorectal cancers in the Syrian population: A tissue microarray study.

Authors:  Noor Al-Antary; Hanan Farghaly; Tahar Aboulkassim; Amber Yasmeen; Nizar Akil; Ala-Eddin Al Moustafa
Journal:  Hum Vaccin Immunother       Date:  2017-03-28       Impact factor: 3.452

5.  Long-term live-cell microscopy with labeled nanobodies delivered by laser-induced photoporation.

Authors:  Jing Liu; Tim Hebbrecht; Toon Brans; Eef Parthoens; Saskia Lippens; Chengnan Li; Herlinde De Keersmaecker; Winnok H De Vos; Stefaan C De Smedt; Rabah Boukherroub; Jan Gettemans; Ranhua Xiong; Kevin Braeckmans
Journal:  Nano Res       Date:  2020-01-18       Impact factor: 8.897

6.  Fascin Rigidity and L-plastin Flexibility Cooperate in Cancer Cell Invadopodia and Filopodia.

Authors:  Isabel Van Audenhove; Majken Denert; Ciska Boucherie; Leen Pieters; Maria Cornelissen; Jan Gettemans
Journal:  J Biol Chem       Date:  2016-03-04       Impact factor: 5.157

7.  A nanobody modulates the p53 transcriptional program without perturbing its functional architecture.

Authors:  Jonas Bethuyne; Steven De Gieter; Olivier Zwaenepoel; Abel Garcia-Pino; Kaat Durinck; Adriaan Verhelle; Gholamreza Hassanzadeh-Ghassabeh; Frank Speleman; Remy Loris; Jan Gettemans
Journal:  Nucleic Acids Res       Date:  2014-10-16       Impact factor: 16.971

8.  p53 controls colorectal cancer cell invasion by inhibiting the NF-κB-mediated activation of Fascin.

Authors:  Xinbing Sui; Jing Zhu; Haimei Tang; Chan Wang; Jichun Zhou; Weidong Han; Xian Wang; Yong Fang; Yinghua Xu; Da Li; Rui Chen; Junhong Ma; Zhao Jing; Xidong Gu; Hongming Pan; Chao He
Journal:  Oncotarget       Date:  2015-09-08

9.  CRP2, a new invadopodia actin bundling factor critically promotes breast cancer cell invasion and metastasis.

Authors:  Céline Hoffmann; Xianqing Mao; Monika Dieterle; Flora Moreau; Antoun Al Absi; André Steinmetz; Anaïs Oudin; Guy Berchem; Bassam Janji; Clément Thomas
Journal:  Oncotarget       Date:  2016-03-22

Review 10.  Nanobodies as Versatile Tools to Understand, Diagnose, Visualize and Treat Cancer.

Authors:  Isabel Van Audenhove; Jan Gettemans
Journal:  EBioMedicine       Date:  2016-04-30       Impact factor: 8.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.